Conf Banner

RGCON 2025

Dear Colleague,

Rajiv Gandhi Cancer Institute and Research Centre organizes its yearly global academic conference with the aim of promoting ongoing medical education and sharing knowledge and expertise from distinguished faculties, both national and international, to benefit our delegates, students, and Professionals.

Registration for 23rd Annual International Conference – RGCON 2025, scheduled to take place from 21st – 23rd March 2025 in Hotel Crowne Plaza, Rohini, New Delhi, India., is now open. The conference theme for this year is “Gynecological cancers: integrating, innovating and updating.” RGCON 2025 promises an enriching experience, with a compelling program featuring the latest groundbreaking advancements and research presented in scientific and educational sessions, complemented by vibrant networking events.

We have curated a comprehensive program that encompasses the latest developments in diagnosis, treatment modalities and survivorship care with an impressive lineup of esteemed renowned speakers, nationally and internationally, this event promises to be a dynamic and enriching experience for all attendees.

Key highlights of the conference include:

International Faculty: Renowned International faculty will discuss the latest advances in area of Gynaecological cancer.

Cutting-Edge Research: Explore groundbreaking research and innovations in the field of Gynae oncology. Learn about Live Surgery, novel therapies, precision medicine approaches, and emerging technologies that are transforming cancer care.

Live Surgery Workshop: We have curated a live Surgical workshop where international and national faculty will perform open and robotic radical Gynae oncological surgeries like Open nerve sparing radical hysterectomy, Robotic Nerve sparing radical hysterectomy with SLN Mapping, Robotic Veil and Robotic Anterior exenteration.

Multidisciplinary Approach: Engage in sessions that promote collaboration among various disciplines, including surgery, radiation oncology, medical oncology, pathology, and supportive care. We believe in the power of teamwork to improve patient outcomes.

Interactive Workshops: Participate in Gynae Onco-Pathology and Gynae Radiation Oncology Workshop to enhance your practical skills and problem-solving abilities. Our workshops are designed to provide practical insights into complex clinical scenarios.

Networking Opportunities: Connect with like-minded professionals, researchers, and industry representatives during our networking events. Forge valuable partnerships and collaborations that can drive progress in the field.

We invite clinicians, researchers, students, and all healthcare professionals with an interest in Gynec oncology to join us for this remarkable event. Together, let’s elevate the standard of care, improve patient outcomes, and make a significant impact on the fight against Gynecological cancers.

Mark your calendars and register early to secure your spot at the RGCON 2025 – Gynecological cancers: integrating, innovating and updating.

We look forward to welcoming you to this transformative event. See you there!

Warm Regards,
Dr. Vandana Jain
Organizing Secretary

Hotel Crowne Plaza, Rohini 21st - 23rd March, 2025

ORGANIZING COMMITTEE

PATRONS
Mr. Rakesh Chopra

Chairman

Mr. D. S. Negi

Chief Executive Officer

Dr. D C Doval

Chair Medical Oncology & Chief of Breast & Thoracic Services

Dr. A K Dewan

Director Surgical Oncology

Dr. Anurag Mehta

Director – Department of Laboratory & Transfusion Services and Director Research

ORGANIZING CHAIRMAN
Dr. Sudhir Rawal

Medical Director

ORGANIZING SECRETARY
Dr. Vandana Jain

Head Gynae Oncology

CO-ORGANIZING SECRETARY
Dr. Ullas Batra

Co -Director Med Oncology and Chief of Thoracic Medical Oncology

Dr. Sumit Goyal

Senior Consultant, Dept. of Medical Oncology

Dr. Anjali K Pahuja

Senior Consultant- Department of Radiation Oncology

Dr. Anila Sharma

Senior Consultant – Histopathology

Dr. Sarika Gupta

Sr. Consultant & Unit Head – Gynae Surgical Oncology (Unit – II)

Faculty

International Faculty
Dr. Baljeet Kaur

Consultant Cellular Pathologist, Regional Lead for Gestational Trophoblast pathology(GTD) and Malignant Ovarian Germ Cell (MOGCT) servicevice, Imperial College Healthcare NHS Trust, London, UK

Dr. Ben Davidson

Senior Pathologist, Department of Pathology, Norwegian Radium Hospital, Oslo University Hospital; Professor, Faculty of Medicine, University of Oslo, Norway

Dr. Christina Fotopoulou

Consultant gynaecological oncologist at Queen Charlotte's & Chelsea Hospital. She was trained in obstetrics and gynaecology at the Charité University Hospital of Berlin with a sub-specialism in gynaecological oncology, Germany

Dr. Denis Querleu

Former president of the European Society of Gynecological Oncology, a visiting professor at Rome’s Gemelli University Hospital, and a consultant at Strasbourg’s IHU, France

Dr. Dennis S. CHI

Chair in Gynecologic Surgery, Deputy Chief of the Gynecology Service, and Head of Ovarian Cancer Surgery at Memorial Sloan Kettering Cancer Center, New York, USA

Dr. Henrik Falconer

Head of Gynecologic Oncology at Karolinska University Hospital and Associate Professor at Karolinska Institute, Sweden

Dr. Jalid Sehouli

Medical Director, Department of Gynecology including center of oncological surgery (CVK) and Department of Gynaecology (CBF), Berlin, Germany

Dr. Jonathan Ledermann

Professor of Medical Oncology and Clinical Director at UCL Cancer Institute, University College London, and a Consultant Medical Oncologist at UCL Hospitals, London

Dr. K. Rainer Kimmig

Chair for Gynecology and Obstetrics at the University of Essen Director of the Clinic for Gynecology and Obstetrics at the University of Essen, Germany

Dr. Mario Leitao

Attending Surgeon & Member, Division of Gynecology/Professor, Weill Cornell Medical College/Director, Gynecologic Oncology Fellowship Program/Director, Minimal Access and Robotic Surgery (MARS)/ Program, Department of Surgery Memorial Sloan-Kettering Cancer Center, New York, USA

Dr. Mustafa Zelal Muallem

Professor for gynecological oncology and oncological surgery. Deputy Director of Department of Gynecology with Center for Oncological Surgery Charité Medical University of Berlin, Germany

Dr. Neville Hacker

Founder and Director of AGCF (Australian Gynaecological Cancer Foundation), Professor of Gynecological Oncology, Conjoint, at the University of NSW, Australia

Dr. Nicolo Bizzarri

ENYGO Past President, IJGC Editorial Board, Gynecologic Oncology Unit, Catholic University of the Sacred Heart Policlinico Agostino Gemelli IRCCS Largo A. Gemelli, Rome (Italy)

Dr. Peter Lim

Medical Director of Gynecologic Oncology and Robotic Surgery at Center of Hope and Clinical Associate Professor of Obstetrics and Gynecology at the University of Nevada Reno School of Medicine, USA

Dr. Robert L. Coleman

Gynecologic Oncologist practicing at Texas Oncology in Houston Inaugural Chief Medical officer for Vaniam Group, an independent healthcare communications agency based in Chicago, Illinois, USA

Dr. Walter Gotlieb

Academic chief at Allegheny health network and a professor of radiation oncology at Drexel University, USA

Dr. Sushil Beriwal

Professor, Department of Obstetrics and Gynecology, Department of Oncology, Director of Surgical Oncology, McGill University, Canada

ABSTRACT SUBMISSION

GENERAL GUIDELINES FOR SUBMISSION:
  • Abstracts must be original and must not be or have been published or presented at any other meeting prior to the 31st RGCON 2025, New Delhi.
  • Abstracts must be submitted online via the website and indicate whether the abstract is for Oral, Poster, Surgical Video Presentation.
  • Only the first author can submit an abstract.
  • Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
  • The Scientific Committee of RGCON 2025 will determine whether the abstract is accepted as an oral presentation or a poster presentation, with consideration given to the author’s preference.
  • Ethical considerations: For clinical trials, details of ethical committee approval and types of informed consent should be stated. Names and initials of patients or volunteers should not be used.
  • In order to submit an abstract, all presenters are required to pay the full registration fees before submitting an abstract.
  • For any further information related to abstract submission, please contact Secretariat by e-mail (rgcon2025@gmail.com)
  • The Abstract should be submitted via email on rgcon2025@gmail.com in the conference abstract submission form only - Click here to download the Abstract submission form
ABSTRACT FORMAT:
  • Capitalize the first letter of all words in your title. However, do not capitalize article words such as “a,” “the,” “and,” & “of” unless the article is the first word of the title.
  • All abstracts must contain the following information: Introduction, Materials & Methods, Results and Conclusion.
  • Abstracts should be no more than 300 words. Tables or figures are not allowed.
ABSTRACT ACCEPTANCE:
  • The Scientific Committee of RGCON 2025 reserves the rights to make the final decision of presentation categories and acceptance/rejection of abstract.
  • Authors will be notified by email no later than 30th November, 2024 whether their abstract has been accepted or rejected.
PRESENTATION TIME:
  • Oral presentations: 6-min each, followed by 2 minute discussion
  • Poster presentations: Poster size is 2.5 Feet Width & 3.5 Feet Height.
  • Surgical video presentations: 10-min well edited video with a title page and narratives.
SUBMISSION TOPICS/ABSTRACT CATEGORY
  • Cervical Cancer
  • Endometrial Cancer
  • Ovarian Cancer
  • Vaginal and Vulvar Cancer
  • Trophoblastic Diseases
  • Other rare gynecological cancers
  • Palliative Care & Quality of Life after Treatment of Gynecologic Cancer
  • Non-invasive disease of Gynecologic Cancer (pre-cancer)
  • Translational Research, Basic science& Novel therapy (ADC, cell therapy...)
  • Surgical techniques (minimally invasive surgery, new method, HIPEC...)
  • Immunotherapy and relevant topics
  • Genomic, biomarker or prognostic marker
  • Artificial intelligence(AI), database
  • Imaging
ABSTRACT SUBMISSION DEADLINE:
  • 15th November 2024
REVIEW, SELECTION & REWARD:
  • Authors of accepted abstracts should do a 10-minute oral presentation on RGCON 2025 Day 1

CONTACT DETAILS

For any query about Registration, please contact:
Mr. Narayan Sharma
M. +91 93777 24324
E. rgcon2025@gmail.com

For any query about Sponsorship, please contact:
Ms. Anju Chauhan
M. +91 98731 55130
E. rgcon2025@gmail.com

For Any query about Scientific Program, please contact:
Dr. Vandana Jain
M. +91 99107 00788
E. rgcon2025@gmail.com

Mr. Shivam Sharma
M. +91 99049 29435
E. rgcon2025@gmail.com

Opportunity to Help

DONATE FOR CANCER CARE

As a society, RGCIRC is looking forward to get support from generous people

Read More
DONATE BLOOD

It is a fact that there are absolutely no substitutes to replace human bloo...

Read More
DONATE TIME (VOLUNTEER)

Volunteers play an important role in today’s hospitals. They help the hos...

Read More

Rajiv Gandhi Cancer Institute & Research Centre is today counted amongst Asia’s premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned super specialists. This potent combination of man and machine ensures world-class cancer care to not only patients from India, but also from the neighboring SAARC countries and others.

D - 18, Sector - 5, Rohini, Delhi - 110085 | +91-11-47022222
OPD Timings: 09:00 am to 05:00 pm (All weekdays except Sunday and Holiday)
Emergency Services: 24x7 All weekdays

Mahendra Kumar Jain Marg, Niti Bagh, New Delhi - 110049 | Tel: +91-11-45822222 / 2200
OPD Timings: 09:00 am to 05:00 pm (All Weekdays except Sunday and Holiday)
Emergency Services: 24x7 All Weekdays

Subscribe Today For Our Healthy Tips Newsletter
Loading